Invention Grant
- Patent Title: Potent and selective inhibitors of hepatitis C virus
-
Application No.: US14936878Application Date: 2015-11-10
-
Publication No.: US09932326B2Publication Date: 2018-04-03
- Inventor: Steven J. Coats , Franck Amblard , Hongwang Zhang , Longhu Zhou , Richard Anthony Whitaker , Tamara Rosario McBrayer , Raymond F. Schinazi , Junxing Shi
- Applicant: Cocrystal Pharma, LLC , Emory University
- Applicant Address: US GA Tucker US GA Atlanta
- Assignee: Cocrystal Pharma, LLC,Emory University
- Current Assignee: Cocrystal Pharma, LLC,Emory University
- Current Assignee Address: US GA Tucker US GA Atlanta
- Agency: Andrews Kurth Kenyon LLP
- Agent David Bradin
- Main IPC: A61K31/4178
- IPC: A61K31/4178 ; C07D403/14 ; C07D403/04 ; C07D405/14 ; C07D413/14 ; A61K31/4192 ; A61K31/444 ; A61K31/506 ; A61K31/5377 ; A61K31/655 ; C07D401/14 ; C07D407/14 ; A61K45/06
Abstract:
The present invention is directed to compounds, compositions and methods for treating or preventing hepatitis C virus (HCV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment or prevention of HCV infection.
Public/Granted literature
- US20160068518A1 POTENT AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS Public/Granted day:2016-03-10
Information query
IPC分类:
